Essayer OR - Gratuit

Dr. Reddy's to focus on complex drugs

Mint New Delhi

|

January 24, 2025

The pharma major posted its highest ever quarterly results and Ebitda this quarter.

- Jessica Jani

Dr. Reddy's is focusing on a pipeline of complex drugs, including GLP-1 (such as Semaglutide), and biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug Revlimid next year, a top executive said.

As Revlimid, the drug that has been the biggest growth driver for the company in recent years, nears its patent expiry in January 2026, the pharma major has additional growth drivers in place to continue the momentum, Erez Israeli, CEO, Dr. Reddy's, said.

Israeli was speaking at a press briefing post the company's Q3FY25 results.

PLUS D'HISTOIRES DE Mint New Delhi

Mint New Delhi

Mint New Delhi

Anju Dodiya creates disquieting worlds

Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'

time to read

5 mins

December 13, 2025

Mint New Delhi

New Delhi and France revise 1992 tax treaty

India and France have struck a deal to revise their 1992 treaty which will halve the tax on dividends paid by Indian units to French parents, potentially saving millions for companies with major operations in the South Asian nation, documents show.

time to read

1 min

December 13, 2025

Mint New Delhi

GST cuts, easing inflation drive rural demand revival

India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.

time to read

2 mins

December 13, 2025

Mint New Delhi

Mint New Delhi

The loss of Srinagar as a cosmopolitan city

Sameer Hamdani's book brings alive the details that once defined life in one of South Asia's oldest cities but stops short of reflecting on the present

time to read

5 mins

December 13, 2025

Mint New Delhi

Mexico duty hikes to hit 75% of India Jan exports

Three-quarters of India’s exports to Mexico are set to face a major setback from 1 January 2026, according to a report released on Friday by Global Trade Research Initiative (GTRI), after the Mexican senate approved steep tariff increases on goods imported from countries that don’t have a free-trade agreement (FTA) with Mexico.

time to read

1 min

December 13, 2025

Mint New Delhi

Nov retail inflation up to 0.71%, as fall in food price eases

India’s retail inflation inched up to 0.71% in November, from a record low of 0.25% in October, primarily driven by a seasonal rise in prices of some food items, which narrowed the deflation for the group.

time to read

1 mins

December 13, 2025

Mint New Delhi

Mint New Delhi

Rajasthan limits e-NAM 2.0 pilot amid snags; 1.0 to stay

The Centre restricted e-NAM 2.0 pilot to 10 mandis, including Tonk, Jodhpur and Sujangarh

time to read

3 mins

December 13, 2025

Mint New Delhi

Mint New Delhi

A modern-day throwback to 'Malgudi Days'

Sita Bhaskar's latest novel revisits writer R.K. Narayan’s legacy to explore class, caste, and community in Mysuru

time to read

4 mins

December 13, 2025

Mint New Delhi

Swiggy QIP: A red flag for long-term wealth creation?

Swiggy Ltd’s ₹10,000 crore qualified institutional placement (QIP) comes barely a year after its initial public offering (IPO).

time to read

2 mins

December 13, 2025

Mint New Delhi

Mint New Delhi

Come for the 'baithak', stay for the shopping

Fashion brands are hosting workshops, talks, music gigs and 'baithaks' to take a culture-first approach to customer loyalty

time to read

4 mins

December 13, 2025

Listen

Translate

Share

-
+

Change font size